166 related articles for article (PubMed ID: 36622529)
1. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
Gholami S; Colby S; Horowitz DP; Guthrie KA; Ben-Josef E; El-Khoueiry AB; Blanke CD; Philip PA; Kachnic LA; Ahmad SA; Rocha FG
Ann Surg Oncol; 2023 Mar; 30(3):1354-1363. PubMed ID: 36622529
[TBL] [Abstract][Full Text] [Related]
2. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
3. SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Ben-Josef E; Guthrie KA; El-Khoueiry AB; Corless CL; Zalupski MM; Lowy AM; Thomas CR; Alberts SR; Dawson LA; Micetich KC; Thomas MB; Siegel AB; Blanke CD
J Clin Oncol; 2015 Aug; 33(24):2617-22. PubMed ID: 25964250
[TBL] [Abstract][Full Text] [Related]
4. Outcome of adjuvant therapy in biliary tract cancers.
McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
[TBL] [Abstract][Full Text] [Related]
6. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
7. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
Ito K; Ito H; Allen PJ; Gonen M; Klimstra D; D'Angelica MI; Fong Y; DeMatteo RP; Brennan MF; Blumgart LH; Jarnagin WR
Ann Surg; 2010 Apr; 251(4):675-81. PubMed ID: 20224368
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant (chemo)radiotherapy for resected extrahepatic cholangiocarcinoma: a meta-analysis.
Shi XQ; Zhang JY; Tian H; Tang LN; Li AL
J Zhejiang Univ Sci B; 2020 Jul; 21(7):549-559. PubMed ID: 32633109
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Ren B; Guo Q; Yang Y; Liu L; Wei S; Chen W; Tian Y
Radiat Oncol; 2020 Jan; 15(1):15. PubMed ID: 31941520
[TBL] [Abstract][Full Text] [Related]
10. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
Kamarajah SK; Bednar F; Cho CS; Nathan H
Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
Hoehn RS; Wima K; Ertel AE; Meier A; Ahmad SA; Shah SA; Abbott DE
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1133-9. PubMed ID: 25976862
[TBL] [Abstract][Full Text] [Related]
15. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
16. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
17. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
18. Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: A systematic review and meta-analysis.
Rangarajan K; Simmons G; Manas D; Malik H; Hamady ZZ
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):684-693. PubMed ID: 31761507
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database.
Dominguez DA; Wong P; Chen YJ; Singh GP; Fong Y; Li D; Ituarte PHG; Melstrom LG
Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38443700
[TBL] [Abstract][Full Text] [Related]
20. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.
Showalter TN; Winter KA; Berger AC; Regine WF; Abrams RA; Safran H; Hoffman JP; Benson AB; MacDonald JS; Willett CG
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1328-35. PubMed ID: 20934270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
